AKBA Akebia Therapeutics, Inc.
Nasdaq · SEC CIK 1517022 · EDGAR
- Bought, last 12 months
- $86.6K 1 purchases by 1 insiders
- Sold, last 12 months
- $963.0K 7 sales by 6 insiders
- Filings on record
- 117 since 2021-09-02, latest 2026-08-10 16:08
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Butler John P. | CEO, Pres, Dir | $86.6K | $474.4K |
| Grund Nicholas | Chief Commercial Off | — | $117.9K |
| Ostrowski Erik | SVP, CFO, CBO, Treas | — | $110.8K |
| Rucci Carolyn M. | SVP, CLO | — | $97.0K |
| Burke Steven Keith | SVP, Chief Medical Off | — | $94.0K |
| Malabre Richard C | SVP, CAO | — | $68.8K |
| FRIESON RON | Dir | — | — |
| Wolf Myles | Dir | — | — |
| Smith Cynthia | Dir | — | — |
| ADAMS ADRIAN | Dir | — | — |
Transactions 131
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-02 | 2023-01-31 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +196.2K | 615.7K | +47% | $0 |
| D | 2023-02-02 | 2023-01-31 | AKBA | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +293.1K | 1.70M | +21% | $0 |
| 2022-09-01 | 2022-08-31 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $0.36 | -1,147 | 418.0K | -0.3% | -$412.92 | |
| D | 2022-06-10 | 2022-06-08 | AKBA | Spellman David A | SVP, CFO, Treas | A - Grant | $0.00 | +200.0K | 328.6K | +156% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +13.7K | 66.0K | +26% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | Wolf Myles | Dir | A - Grant | $0.00 | +13.7K | 37.7K | +57% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | GILMAN STEVEN C | Dir | A - Grant | $0.00 | +13.7K | 57.1K | +32% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | ADAMS ADRIAN | Dir | A - Grant | $0.00 | +13.7K | 104.8K | +15% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | Smith Cynthia | Dir | A - Grant | $0.00 | +13.7K | 65.2K | +27% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | FRIESON RON | Dir | A - Grant | $0.00 | +13.7K | 13.7K | New | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | ZUMWALT LEANNE M | Dir | A - Grant | $0.00 | +13.7K | 13.7K | New | $0 |
| 2022-06-07 | 2022-06-03 | AKBA | GILMAN STEVEN C | Dir | S - Sale | $0.36 | -4,567 | 43.4K | -10% | -$1,644 | |
| D | 2022-05-16 | 2022-05-12 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +200.0K | 417.7K | +92% | $0 |
| 2022-05-16 | 2022-05-12 | AKBA | Cotreau Violetta | SVP, CAO | A - Grant | $0.00 | +150.0K | 220.0K | +214% | $0 | |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Hadas Nicole R. | SVP, CLO | S - Sale | $2.16 | -21.1K | 308.9K | -6% | -$45.6K |
| D | 2022-03-02 | 2022-02-28 | AKBA | Hadas Nicole R. | SVP, CLO | A - Grant | $0.00 | +50.0K | 315.7K | +19% | $0 |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $2.16 | -15.1K | 217.7K | -6% | -$32.5K |
| D | 2022-03-02 | 2022-02-28 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +60.0K | 223.8K | +37% | $0 |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Faulkingham Dell | SVP, CCO | S - Sale | $2.16 | -13.2K | 130.5K | -9% | -$28.5K |
| D | 2022-03-02 | 2022-02-28 | AKBA | Faulkingham Dell | SVP, CCO | A - Grant | $0.00 | +50.0K | 180.5K | +38% | $0 |
| D | 2022-03-02 | 2022-02-28 | AKBA | Cotreau Violetta | SVP, CAO | A - Grant | $0.00 | +40.8K | 70.0K | +140% | $0 |
| D | 2022-03-02 | 2022-02-28 | AKBA | Cotreau Violetta | SVP, CAO | S - Sale | $2.15 | -3,946 | 29.1K | -12% | -$8,484 |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Dahan Michel | SVP, COO | S - Sale | $2.16 | -21.5K | 302.1K | -7% | -$46.6K |
| D | 2022-03-02 | 2022-02-28 | AKBA | Dahan Michel | SVP, COO | A - Grant | $0.00 | +50.0K | 309.0K | +19% | $0 |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Spellman David A | SVP, CFO, Treas | S - Sale | $2.15 | -8,203 | 128.6K | -6% | -$17.7K |
| D | 2022-03-02 | 2022-02-28 | AKBA | Spellman David A | SVP, CFO, Treas | A - Grant | $0.00 | +60.0K | 129.4K | +86% | $0 |
| D | 2022-03-02 | 2022-02-28 | AKBA | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +293.1K | 1.46M | +25% | $0 |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Butler John P. | CEO, Pres, Dir | S - Sale | $2.16 | -79.0K | 1.43M | -5% | -$171.0K |
| A | 2022-02-18 | 2018-12-12 | AKBA | Butler John P. | CEO, Pres, Dir | J - Other | — | +1,248 | 375.9K | +0.3% | — |
| 2022-01-05 | 2022-01-03 | AKBA | Cotreau Violetta | SVP, CAO | S - Sale | $2.29 | -5,833 | 33.1K | -15% | -$13.4K | |
| 2021-09-02 | 2021-08-31 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $2.83 | -1,042 | 171.2K | -0.6% | -$2,949 |
Purchase Sale Sale after option exercise All abbreviations